Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $12.97, but opened at $13.29. Gyre Therapeutics shares last traded at $12.90, with a volume of 1,740 shares changing hands.
Gyre Therapeutics Stock Up 1.8 %
The company has a fifty day moving average price of $12.50 and a two-hundred day moving average price of $13.41.
Gyre Therapeutics (NASDAQ:GYRE – Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $25.23 million during the quarter. On average, sell-side analysts expect that Gyre Therapeutics, Inc. will post -0.45 earnings per share for the current fiscal year.
Institutional Trading of Gyre Therapeutics
About Gyre Therapeutics
Gyre Therapeutics, Inc, a biopharmaceutical company, primarily focuses on the development and commercialization of Hydronidone for the treatment of Metabolic Dysfunction Associated Steatohepatitis in the United States. Its Hydronidone is also being evaluated for the treatment of liver fibrosis across a spectrum of chronic liver diseases.
Recommended Stories
- Five stocks we like better than Gyre Therapeutics
- How to Effectively Use the MarketBeat Ratings Screener
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- Why Are These Companies Considered Blue Chips?
- This Is the Entry Into PepsiCo You’ve Been Waiting For
- Consumer Staples Stocks, Explained
- 3 Dividend-Paying Chip Stocks You Don’t Want to Miss
Receive News & Ratings for Gyre Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyre Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.